VESTI

{:sr}{:sr}

proslava Srpskog društva istraživača raka

U petak 2. septembra 2022. godine u 13 časova u prijatnom ambijentu Instituta za biološka istraživanja „Siniša Stanković“ održana je proslava Srpskog društva istraživača raka. Tokom proslave najavljena je nova inicijativa Upravnog odbora „SDIR Naučni dani“, koja ima za cilj uključivanje istraživača raka iz naučnih instituta i fakulteta iz različitih gradova u Srbiji u rad SDIR-a. Prvi sastanak „SDIR Naučni dani“ će biti održan na Državnom univerzitetu u Novom Pazaru 20. septembra 2022. godine, kao hibridni događaj.

Tokom proslave takođe je najavljeno i uspostavljanje Godišnje SDIR nagrade za najbolji naučni rad u oblasti onkologije i sponzorisanje odlaska na HDIR-6 kongres. U okviru inicijative za uspostavljanje naučne saradnje sa nacionalnim naučnim društvima, predstavnici su se obratili skupu i uveličali slavlje: Srpsko društvo za molekularnu biologiju (Dr Ana Đorđević, IBISS), Biohemijsko društvo Srbije (Prof. dr Milica Popović, Hemijski fakultet, UB), Kancerološka sekcija Srpskog lekarskog društva (Dr Nada Santrač, IORS), Srpsko društvo za ekstracelularne vezikule (Dr Sanja Goč, INEP) i Udruženje medikalnih onkologa Srbije (Prim. dr Davorin Radosavljević, IORS).

Proslavi su prisustvovali članovi naučne zajednice i prijateljskih kuća koje kontinuirano podržavaju rad SDIR-a: Alfa Genetics, Alfamed, AstraZeneca, DSP Chromatography, Elta 90MS, Labena, Merck, Roche, Superlab i Vivogen.

Održan je godišnji kongres EACR-a

Drage kolege i članovi SDIR-a,

Godišnji kongres EACR-a pod nazivom „Innovative Cancer Science: Translating Biology to Medicine” održan je od 20-23. juna 2022. godine u Sevilji, Španija. Kongers je bio odlična prilika da se saznaju najnovija dostignuća iz oblasti bazičnog i translacionog istraživanja raka.

Na EACR 2022 su sa svojim posterskim prezentacijama učestvovale koleginice Sofija Jovanović (Institut za biološka istraživanja “Siniša Stanković”), Katarina Zeljić (Biološki fakultet), Katarina Živić, Kristina Živić i Aleksandra Stefanović (Institut za onkologiju i radiologiju Srbije). Katarina Zeljić i Aleksandra Stefanović su dobitnice EACR stipendije za mlade istraživače što im je omogućilo da prisustvuju ovako važnoj konferenciji.

Srdačan pozdrav,
UO SDIR-a

Godišnji sastanak AACR-a

Marijana Pavlović, PhD, istraživač saradnik na Odeljenju za eksperimentalnu onkologiju na Institutu za onkologiju i radiologiju Srbije (IORS) dobitnik je prestižne nagrade Global Scholar-in-Training Award (GSITA) koju dodeljuje Američko udruženje za istraživanje raka (American Association for Cancer Research, AACR) perspektivnim mladim istraživačima koji žele da učestvuju na godišnjem sastanku AACR-a. Cilj ove nagrade je da unapredi obrazovanje i proširi profesionalnu mrežu naučnika koji dolaze iz zemalja koje grade kapacitete za istraživanje raka, auključeni su u osnovna, klinička, translaciona ili epidemiološka istraživanja raka. Marijana je odabrana kao jedan od 15 ovogodišnjih dobitnikaAACR GSITA nagrade u znak priznanja za izvanredan predloženi apstrakt odabran za prezentaciju na godišnjem sastanku AACRu aprilu 2022. godine u Nju Orleansu (Luizijana, SAD). Rezultati prikazani na konferenciji u vidu postera pod nazivom Nischarin agonist rilmenidine inhibits pancreatic ductal adenocarcinoma cell migration and invasion su proistekli iz projekta REPANCAN kojim rukovodi Dr Jelena Grahovac, a finansiranje od strane Fonda za nauku Republike Srbije i Horizon 2020 MSC grantom.

Link ka dobitnicima 2022 AACR GSITA nagrade: www.aacr.org

EACR25, 25. kongres Evropske asocijacije za istraživanje raka

EACR25, 25. Bianualni kongres evropske asociijacije za istraživanje raka u Amsterdamu u Holandiji je bio sjajna prilika za nas da čujemo najnovija dostignuća iz oblasti bazičnog i translacionog istraživanja raka. Naročito su nam bili zanimljivi simpozijumi o kancer mikrosredini i napretku u imunoterapiji. EACR25 bio je izuzetna prilika za nas da prezentujemo naše rezultate i upoznamo potencijalne saradnike.

Ovim putem želimo da se zahvalimo SDIR-u za pruženu šansu da prisustvijemo ovako važnoj konferenciji koja je nam bila izuzetno profesionalno iskustvo.

Jelena Grahovac i Marijana Pavlović, Institut za onkologiju i radiologiju Srbije.

Marijana Pavlović Marijana Pavlović i Jelena Grahovac

Izveštaj o učešću – Tamara Babić, istraživač pripravnik

Od 8. do 12. oktobra 2018. godine održana je letnja škola pod nazivom „Summer School in Translational Cancer Research“ koju je organizovao German Cancer Consortium (DKTK) pod pokroviteljstvom Cancer Core Europe i uz podršku European Association for Cancer Research (EACR). Skup je održan na južnoj obali Portugala, u mestu Albufeira. Učesnici ovog skupa bili su mladi istraživači i lekari, koji su na svojim doktorskim studijama ili su ih nedavno završili, a bave se translacionim istraživanjem raka. Zahvaljujući stipendijama Srpskog društva istraživača raka i Cancer Core Europe, dobila sam priliku da učestvujem u ovoj školi. Moje ime je Tamara Babić, doktorsku tezu radim na Institutu za molekularnu genetiku i genetičko inženjerstvo i bavim se ulogom alternativnih promotora gena SMAD4 u razviću i karcinogenezi.

Glavni fokus letnje škole jeste translacija bazičnih istraživanja raka do nivoa kliničkih studija i primene njihovih rezultata u zdravstvenim sistemima. Predavanja su držali prepoznati naučnici koji su obrađivali teme vezane za integraciju precizne medicine u dijagnostikovanje i lečenje malignih bolesti, kliničke studije u oblasti onkologije, izmenjen metabolizam u tumorima, biomarkere za prevenciju, dijagnozu i lečenje malignih bolesti, povezanost infekcije i tumora i imunoterapijski pristup. Takođe, govorilo se o uticaju nauke na donošenje relevantnih zakona i o naučnoj diplomatiji.

Tokom celodnevnih boravaka zajedno, učesnici su imali prilike da i neformalno razmenjuju informacije na obali Portugala ili tokom zajedničkog ručka. Posebno je interesantno bilo to što se učesnici bave različitim granama nauke, pa su se razmenjivala znanja iz oblasti bioinformatike i modernih sistema „deep learning“, savremenih kliničkih studija i bazičnih istraživanja molekularne biologije tumora koja uključuju rad na različitim model sistemima. Predavači su bili dostupni i raspoloženi za diskusiju tokom predavanja, ali i svako veče u okviru aktivnosti „Meet the professor“.

Učesnici su prezentovali svoja istraživanja u okviru poster sekcija ili kratkih predavanja. Letnja atmosfera u oktobru i fenomenalna predavanja i diskusije pretvorile su školu u veoma korisno i zabavno iskustvo. Svakako, dugujem veliku zahvalnost SDIR-u koji je odobrenim sredstvima pomogao moje učešće u letnjoj školi, koje inače ne bi bilo moguće.

Tamara Babić, istraživač pripravnik
Institut za molekularnu genetiku i genetičko inženjerstvo
Vojvode Stepe 444A, Beograd
tamarakovacevic@imgge.bg.ac.rs


Summer School in Translational Cancer Research“, Albufeira, Portugal

Izveštaj o učešću – Dr Mirjana Brankovic-Magic, predsednica SDIR i Dr Ana Krivokuća

Dr Mirjana Branković-Magić, predsednica Srpskog drustva istrazivaca raka i Dr Ana Krivokuca, clan ovog drustva su u periodu od 11.10. do 14.10. kao predavaci po pozivu ucestvovale na Sedmom multidisciplinarnom kongresu za istrazivanje raka i prvom onkoloskom kongresu (7th Multidiscipilinary Cancer Research & 1st Basic Oncology Congress) u Izmiru u Turskoj.

Dr Mirjana Branković-Magić je održala predavanje pod nazivom “Hereditary breast cancer-looking beyond BRCA genes” pri cemu je predstavila visegodisnje rezultate istrazivanja koji se sprovode u Laboratoriji za molekularnu genetiku Instituta za onkologiju i radiologiju Srbije a ticu se naslednog karcinoma dojke i jajnika. Zahvaljujuci Srpskom drustvu istrazivaca raka koje je stipendijom pomoglo putne troskove, Dr Ana Krivokuca je imala priliku da predstavi je process klasifikacije genetickih varijanti upotrebom nove tehnologije sekvenciranja na ovom kongresu. Predavanjem pod nazivom “Complexities of variant annotation using NGS” prikazala je nacin na koji se ovaj proces sprovodi na Institutu za onkologiju I radiologiju Srbije kao I probleme koje ovaj slozen process nosi sa sobom.

Pored prilike da predstave rezultate svojih istrazivanja, imale su priliku i da cuju radove predavaca iz razlicitih krajeva Evrope i sveta. Ova poseta doprinela je nastavku dugogodisnje saradnje koje imaju srpsko i tursko drustvo za istrazivanje raka.

Ana Krivokuća i predsednica SDIR-a Mirjana Branković-Magić Ana Krivokuća predsednica SDIR-a Mirjana Branković-Magić

{:}{:en}

SDIR SCIENTIFIC DAYS

PROMOTION OF SDIR ACTIVITIES AND STRENGTHENING COOPERATION AMONG CANCER RESEARCH CENTERS IN SERBIA

September 20, 2022, State University of Novi Pazar, Serbia and online

SDIR Scientific Days is a new initiative of the Executive Committee of SDIR and is envisioned to become traditional – organized once or twice per year. Lectures from the SDIR Scientific Days will be streamed online and all registered SDIR or EACR members will be able to follow the proposed Program of the event.

The first SDIR Scientific days event will be held on September 20, 2022, at the State University of Novi Pazar, Serbia. Members of the Executive Committee of SDIR will be present in person to familiarize themselves with the resources (both material and human) for cancer research at the State University of Novi Pazar. Ongoing research will be presented by Prof. NatašaĐorđević, Prof. Tanja Soldatović and Prof. Milan Dekić. They will also present their research capacities, scientific interest, and the possibility of cooperation with other cancer centers and laboratories in Serbia.

Registration for the event:

You are invited to a Zoom meeting.
When: Sep 20, 2022 11:00 AM Belgrade, Bratislava, Ljubljana

Register in advance for this meeting:

Link: us06web.zoom.us

After registering, you will receive a confirmation email containing information about joining the meeting.

This meeting is sponsored by the European Association of Cancer Research

AACR Annual Meeting

Marijana Pavlović, PhD, Research Assistant at the Department of Experimental Oncology from the Institute for Oncology and Radiology of Serbia (IORS) received the prestigious Global Scholar-in-Training Award (GSITA) from the American Association for Cancer Research (AACR). AACR offers GSITA awardto support the participation of the promising early-career scientists in the AACR Annual Meeting. This award is intended to enhance the education, training, and professional network of scientists from the countries building cancer research capacities who are engaged in basic, clinical, translational, or epidemiological cancer research.Marijana was selected as one of the fifteenrecipients of this year’sAACR GSITAaward in recognition of a meritoriousproffered paper selected for presentation at the AACR Annual Meeting in April 2022 in New Orleans (Louisiana, USA). The results presented at the conference in the form of poster entitled Nischarin agonist rilmenidine inhibits pancreatic ductal adenocarcinoma cell migration and invasionare part of the REPANCAN project led by Dr Jelena Grahovacand funded by the Science Fund of the Republic of Serbia and Horizon 2020 MSC grant.

Link to 2022 AACR GSITA awardees: www.aacr.org

The EACR25, 25th Congress of the European Association for Cancer Research

The EACR25, 25th Congress of the European Association for Cancer Research in Amsterdam, Netherlands was a great venue for us to hear the latest developments in basic and translational cancer research. We especially enjoyed symposia on cancer microenvironment and advances in immunotherapy. EACR 25 was also an exceptional opportunity for us to present our current research and meet potential collaborators.

We want to thank SDIR for the opportunity to attend this important meeting, which has been a great professional experience for us.

Jelena Grahovac and Marijana Pavlović, Institute for Oncology and Radiology of Serbia.

Marijana Pavlović Marijana Pavlović i Jelena Grahovac

Participation report – Tamara Babić, Research Assistant

„Summer School in Translational Cancer Research” was held from 8th until 12th of October and was organized under the umbrella of Cancer Core Europe in collaboration with the German Cancer Consortium (DKTK) and was supported by the European Association for Cancer Research (EACR). Meeting took place on the southern cost of Portugal in Albufeira. Participants were young career researchers and medical doctors on their PhD studies or who have just obtained PhD degree, that work in the field of translational cancer research. Owing to the scholarships provided by Serbian Association for Cancer Research and Cancer Core Europe, I have got the opportunity to participate in Summer School. My name is Tamara Babic and I am investigating the role of SMAD4 alternative promoters in development and carcinogenesis at the Institute of Molecular Genetics and Genetic Engineering.

Main topic of the Summer School is translation from basic cancer research to clinical trials and its results implementation in the health care systems. Well recognized lecturers dealt with up-to-date topics related to precision medicine in diagnosis and treatment of malignant diseases, clinical studies in oncology, altered metabolism in cancer cells, biomarkers for prevention, diagnosis and treatment of malignant diseases, infection-tumor relation and immunotherapy. Furthermore, there were lectures about scientific influence in designing relevant laws and importance of scientific diplomacy.

Spending whole day together, participants had the opportunity to exchange the knowledge informally on the Portuguese coast or during lunch time. Especially interesting was the fact that participants are into quite different science branches, from bioinformatics and deep learning, through modern clinical studies, to basic research in cancer molecular biology which includes different model systems. Lecturers were available for and interested in discussion during lectures, but also during special social activity “Meet the professor” after dinner time.

Participants presented their research as posters or short oral presentations. Summer vibes in October and fantastic lectures and discussions provided useful and funny experience. I am very thankful for being awarded a travel grant provided by SDIR for attending Summer School. Without the grant I would not be able to participate and gain such an experience.

Tamara Babić, Research Assistant
Institut za molekularnu genetiku i genetičko inženjerstvo
Vojvode Stepe 444A, Beograd
tamarakovacevic@imgge.bg.ac.rs


Summer School in Translational Cancer Research“, Albufeira, Portugal

Participation report – Dr Mirjana Branković-Magić, SDIR president and Dr Ana Krivokuća

Dr Mirjana Branković-Magić, president of Serbian Association for Cancer Research and Dr Ana Krivokuca, member, were invited by the organizers to give the lectures on 7th Multidiscipilinary Cancer Research & 1st Basic Oncology Congress that was held from 11th to 14th October 2018 in Izmir, Turkey.

Dr Mirjana Branković-Magić gave the lecture “Hereditary breast cancer- looking beyond BRCA genes” where she presented the results of the research on genetics of hereditary breast and ovarian cancers that has been conducted at the Laboratory for Molecular Genetics at the Institute for Oncology and Radiology of Serbia for more than 10 years. Thanks to the travel grant from Serbian Association for Cancer Research, Dr Ana Krivokuca had the opportunity to give the lecture on the complex process of variant annotation in the era of next generation sequencing. She presented this process and the way it has been conducted at the Institute for Oncology and Radiology of Serbia through the lecture “Complexities of variant annotation using NGS”.

Besides the opportunity to present their research, Dr Mirjana Brankovic-Magic and Dr Ana Krivokuca had the opportunity to meet and hear the lectures from all over the world. This visit made important contribution to the long term collaboration that exists between Serbian and Turkish Associations for Cancer Research.

Ana Krivokuća and SDIR president Mirjana Branković-Magić Ana Krivokuća SDIR president Mirjana Branković-Magić

{:}